RNA-Seq Blog Transcriptome Research & Industry News
While trying to develop a comparatively easy, inexpensive way to give physicians and their patients with bladder cancer a better idea of likely outcome...
Read More »Long-standing, comparatively easy pathology tests outperforms new RNA-Seq methods
Novel fusion transcripts in bladder cancer identified by RNA-seq
Urothelial carcinoma (UC) is the most common type of bladder cancer and is the second most frequently diagnosed genitourinary tumor. The identification of fusion genes in bladder cancer might provide new perspectives for its classification and significance. Researchers from the ...
Read More »Clinical Application of RNA-Seq – Bladder Cancer
Brief information on bladder cancer and its relation to RNA Seq
Read More »The MicroRNA Expression Signature of Bladder Cancer by Deep Sequencing
Current genome-wide microRNA (miRNA) expression signature analysis using deep sequencing technologies can drive the discovery of novel cancer pathways regulated by oncogenic and/or tumor suppressive miRNAs. Researchers at Kagoshima University, Japan determined the genome-wide miRNA expression signature in bladder cancer ...
Read More »